![James Bucher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Bucher
General Counsel at
HARPOON THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2026
Profile
James B. Bucher currently works at Harpoon Therapeutics, Inc., as Chief Legal Officer from 2023 and Zentalis Pharmaceuticals, Inc., as Secretary & Chief Legal Officer from 2025.
Mr. Bucher also formerly worked at Exelixis, Inc., as Secretary & Vice President-Corporate Legal Affairs from 2013 to 2014, Shearman & Sterling LLP, as Partner from 2001 to 2007, Lundbeck Seattle BioPharmaceuticals, Inc., as Executive Vice President & General Counsel, and Climb Bio, Inc., as Executive Vice President & General Counsel.
Mr. Bucher received his undergraduate degree from Colgate University and graduate degree from Emory University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
James Bucher active positions
| Companies | Position | Start |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | General Counsel | 26/12/2023 |
| ZENTALIS PHARMACEUTICALS, INC. | General Counsel | 18/09/2025 |
Former positions of James Bucher
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | General Counsel | 01/01/2014 |
Shearman & Sterling LLP
 Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Corporate Officer/Principal | 01/01/2007 |
| CLIMB BIO, INC. | General Counsel | - |
| ALDER BIOPHARMACEUTICALS, INC. | General Counsel | - |
Training of James Bucher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Shearman & Sterling LLP
Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Emory University School of Law
 Emory University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
- Stock Market
- Insiders
- James Bucher
